English
Русский
O'zbek
THE ROLE OF CYSTATIN C IN ASSESSING THE FUNCTIONAL STATE OF THE KIDNEYS IN PATIENTS WITH CORONARY HEART DISEASE
General information about the article
Diagnosis and treatment of chronic coronary heart disease (CHD) is well developed, but there are often difficulties in managing patients with comorbid diseases. A very common chronic kidney disease (CKD) occupies a special place among comorbidities. The cause of death in patients with kidney dysfunction is significantly more often CHD than end-stage renal disease (ESRD). In recent years, cystatin C has been considered as an early marker for assessing the functional state of the kidneys and cardiovascular risk, the level of which, unlike creatinine, does not depend on gender, age, race, and muscle mass.
1. Belyalov F.I. Ischemic heart disease and impaired renal function. Rational pharmacotherapy in cardiology 2017;13(3):409-415.
2. Russian Journal of Cardiology 2014, 8 (112): 7–37
3. R EDUCED GLOMERAL FILTRATION RATE AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE A.V. Smirnov, V.M. Sedov, Lhaahuu Od-Erdene, I.G. Kayukov, V.A. Dobronravov, I. Yu. Panina 2016
4. Usacheva E.V., Mikhailova L.V., Nelidova A.V., Zamakhina O.V. FUNCTIONAL STATE OF THE KIDNEYS IN PATIENTS AFTER MYOCARDIAL INFARC TION // Modern problems of science and education. - 2015. - No. 4.
5. Afshinnia F, Spitalewitz S, Chou SY, Gunsburg DZ, Chadow HL. Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure. Am J Kidney Dis. 2007;49(2):227-236.
6. Breidthardt, T. Diagnostic and prognostic value of cystatin C in acute heart failure / T. Breidthardt, Z. Sabti, R. Ziller, F. Rassouli, R. Twerenbold,N. Kozhuharov, E. Gayat, S. Shrestha, S. Barata, P. Badertscher, J. Boeddinghaus, T. Nestelberger, C. Mueller // Clin Biochem. - 2017. - Vol. 50, № 18. -Р. 1007-1013
7. Coresh1 J., Stevens L., Levey A. Chronic kidney disease is common: What do we do next? Nephrol Dial Transplant. 2008; 23(8): 1122-1125.
8. Correa, S. Cystatin C for risk stratification in patients after an acute coronary syn drome / S. Correa, D.A. Morrow, E. Braunwald, R.Y. Davies,E.L. Goodrich, S.A. Murphy, C.P. Cannon, M.L. O'Donoghue // J Am Heart Assoc. - 2018. - Vol. 7, № 20.
9. Deo R, Fyr CL, Fried LF, et al.. "Kidney dysfunction and fatal cardiovascular dis ease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study". Am. Heart J. 2008. 155 (1): 62–8.
10. Djoussé L, Kurth T, Gaziano JM (January 2008). Cystatin C and risk of heart fail ure in the Physicians' Health Study (PHS)". Am. Heart J. 155 (1): 82–6.
11. Delanaye P, Cavalier E, Krzesinski JM et al Cystatin C, renal function, and cardio vascular risk"Ann. Intern. Med. 2008, 148 (4): 323.
12. Eckel, R.H. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Car diovascular Risk [Text] / R.H. Eckel, J.M. Jakicic, J.D. Ard, N.H. Miller, V.S. Hub bard, C.A. Nonas, J.M. de Jesus, F.M. Sacks, I.-M. Lee, Jr.S.C. Smith, A.H. Lich tenstein, L.P. Svetkey, C.M. Loria, T.W. Wadden, B.E. Millen, S.Z. Yanovski // Journal of the American College of Cardiology. – 2013, doi: 10.1016/j.jacc.2013.11.003
13. Elsayed, M.S. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus / M.S. Elsayed, A. El Badawy, A. Ahmed,R. Omar, A. Mohamed // Diabetes Metab Syndr. - 2019. - Vol. 13, № 1. -Р. 374-381.
14. Finney H, Newman DJ, Thakkar H,et al. "Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children". Arch. Dis. Child. 2000, 82 (1): 71–5.; Ognibene A, Mannucci E, Caldini A, et al.. Cystatin C reference values and aging". Clin. Biochem 2006, .39 (6): 658–61.
15. Koenig W, Twardella D, Brenner H, et al. . Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate". Clin. Chem. 2005 51 (2): 321–7.
16. Liu, X. Is the chronic kidney disease epidemiology collaboration creatinine-cystatin C equation useful for glomerular filtration rate estimation in the elderly / X. Liu, H. Ma, H. Huang [et al] // Clin Interv Aging. - 2013. - № 8. -Р. 1387-1391.
17. Luis-Lima, S. An overview of errors and flaws of estimated GFR versus true GFR in patients with diabetes mellitus / S. Luis-Lima, E. Porrini //Nephron. - 2017. - Vol. 136, № 4. - Р. 287-291. 18. Luc G, Bard JM , Lesueur C et al. Plasma cystatin-C and development of coronary heart disease: the PRIME study. Atherosclerosis 185 (2006) 375-380.
19. Parsh J., Seth M., Aronow H., et al. Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Pa tients With Chronic Kidney Disease Undergoing PCI. J Am Coll Cardiol. 2015;65(25):2714-23.
20. Porrini, E. Remuzzi estimated GFR: time for a critical appraisal /E. Porrini,P. Rug genenti, S. Luis-Lima, F. Carrara, A. Jiménez, A.P.J. de Vries, A. Torres, F. Gaspari // GNat Rev Nephrol. - 2018.
21. Ravn, B. Superiority of serum cystatin C over creatinine in prediction of long-term prognosis at discharge from ICU / B. Ravn, J.R. Prowle, J. Mårtensson, C.R. Martling, M. Bell // Crit Care Med. - 2017. -Vol. 45, № 9. - Р. 932-940.
22. Rifkin D, Shlipak MG, Katz R, et al.: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008; 168: 2212–8.
23. Scheen A.J. Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease. Expert Opin Drug Metab Toxicol 2013; 9 (5): 529— 550.
24. Shen, G. Increased cystatin C level in ST-elevation myocardial infarction predis poses the prognosis of angioplasty / G. Shen, H. Zhu, H. Ding,C. Sun, K. Zhou, Y. Fan, T. Li, M. Men, Y. Chen, Q. Lu, A. Ma // Am J. Med Sci. - 2018. - Vol. 355, № 6. - Р. 530-536.
25. Shlipak MG, Katz R, Kestenhbaum B, et al..: Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol 2009; 30: 171–8.)
26. Waldeyer C., Karakas M., Scheurle C., et al. The predictive value of different equa tions for estimation of glomerular filtration rate in patients with coronary artery disease — Results from the AtheroGene study. Int J Card. 2016;221:908-13.
, R. ., & , M. . (2025). THE ROLE OF CYSTATIN C IN ASSESSING THE FUNCTIONAL STATE OF THE KIDNEYS IN PATIENTS WITH CORONARY HEART DISEASE. ALFRAGANUS, 3(4), 22–30. https://doi.org/
, Rakhimova M.E., and Muzaffarov J.Sh. ,. “THE ROLE OF CYSTATIN C IN ASSESSING THE FUNCTIONAL STATE OF THE KIDNEYS IN PATIENTS WITH CORONARY HEART DISEASE.” Academic Research in Educational Sciences, vol. 4, no. 3, 2025, pp. 22–30, https://doi.org/.
, . and , . 2025. THE ROLE OF CYSTATIN C IN ASSESSING THE FUNCTIONAL STATE OF THE KIDNEYS IN PATIENTS WITH CORONARY HEART DISEASE. Academic Research in Educational Sciences. 4(3), pp.22–30.